XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Class A Common Stock, Class B Common Stock and Class C Capital Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2021 $ 5,341 $ (336) $ 0 $ 7,001 $ (492) $ (1,667) $ 156 $ 7
Beginning Balance (in shares) at Dec. 31, 2021     250,630          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common and capital stock upon exercise of stock options 36     36        
Issuance of common and capital stock upon exercise of stock options (in shares)     807          
Vesting of restricted stock units (in shares)     689          
Share-based compensation expense 101     101        
Repurchases of Class A common stock and Class C capital stock (348)     (348)        
Repurchases of Class A common stock and class c capital stock (in shares)     (5,858)          
Net income (loss) 16         16    
Other comprehensive loss (8)             (8)
Ending Balance at Mar. 31, 2022 4,802   $ 0 6,298   (1,495)   (1)
Ending Balance (in shares) at Mar. 31, 2022     246,268          
Beginning Balance at Dec. 31, 2022 4,482   $ 0 6,109   (1,612)   (15)
Beginning Balance (in shares) at Dec. 31, 2022     234,268          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common and capital stock upon exercise of stock options $ 13     13        
Issuance of common and capital stock upon exercise of stock options (in shares) 373   373          
Vesting of restricted stock units (in shares)     1,365          
Share-based compensation expense $ 121     121        
Repurchases of Class A common stock and Class C capital stock (86)     (86)        
Repurchases of Class A common stock and class c capital stock (in shares)     (2,012)          
Net income (loss) (22)         (22)    
Other comprehensive loss 12             12
Ending Balance at Mar. 31, 2023 $ 4,520   $ 0 $ 6,157   $ (1,634)   $ (3)
Ending Balance (in shares) at Mar. 31, 2023     233,994